FROZ Stock Chart 0.0029 06/12/2014 00:54:29

Time to Set the Record Straight: Why Home Care Deserves Our Attention Out here in Pittsfield, Massachusetts, there's a showdown brewing between the Berkshire Visiting Nurse Association (BVNA) and its dedicated crew—those frontline warriors delivering care where it's most personal, right at home. Picture this: a petition lands squarely on the management's desk at 4 p.m....

A Shot of Confidence for Danaos Here's one to mull over—Moody's just gave Danaos Corporation a well-deserved pat on the back. With a nudge in the right direction, they've switched up the outlook on Danaos' Ba1 Corporate Family Rating from stable to positive. Not only that, but they've given a thumbs up to their senior unsecured notes, bumping them from Ba2 to Ba1. Why...

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

A Hard Look at the Numbers for Biddance AI Diving into Biddance AI Systems' first half of 2026 financial results, you can't ignore the taste of both progress and predicament. The revenue leapt to $1.23 million from $0.74 million year-on-year, a decent hike, sure, but let's not pop the champagne just yet. The net loss ballooned too, hitting $1.37 million compared to last...

What's Happened with Endava? Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems. A...

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

A New Dawn for Endometrial Cancer Treatment Alright, every once in a while, something shakes up the world of oncology. And that's exactly what's happening with sacituzumab tirumotecan, or sac-TMT if you want to save your breath. This new drug is stepping up as a future star in the fight against endometrial cancer, according to an eye-popping international study led by NYU...

Incubator Conference Lights Up Lingang Hold onto your hats, folks! Shanghai's Lingang Center is buzzing with activity as the 'World Top-performing Incubator Conference 2026' kicks off. Taking place from October 26 to 28, this gathering isn't just another run-of-the-mill tech meet-up. Oh no, it's about redefining how we talk about innovation, incubation, and the future,...

Welcoming Dr. Chitra Rajagopal to the Oncology Team American Oncology Network (AON), known for its rapid growth in community-based oncology practices, proudly announces the addition of Dr. Chitra Rajagopal, an esteemed medical oncologist. Her presence enhances the physician care team at The Center for Cancer and Blood Disorders, where she will be treating patients in the...

Earnings Forecast for Rapid Micro Biosystems Rapid Micro Biosystems (NASDAQ: RPID) is poised to reveal its quarterly earnings soon. Investors are eager to see if the company can meet or exceed analyst expectations, particularly as they await the announcement regarding an estimated earnings per share (EPS) of $-0.26. This figure serves as a benchmark, providing insight...

Understanding Recent Options Activity of AppLovin In the world of stocks and investments, intriguing signals often emerge, especially when deep-pocketed investors begin to take interest. Recently, AppLovin (NASDAQ: APP) has captured the attention of many with its unusual options activity, hinting at potential market movements that traders shouldn't overlook. A Surge in...

Empowering Youth Against Corruption: ICAC's Landmark Program The Hong Kong International Academy Against Corruption, in collaboration with key international partners, has successfully launched the first-ever regional capacity building program focused on engaging youth in anti-corruption efforts. This initiative is crucial for fostering a culture of integrity among young...

Innovaderm Research Expands into Rheumatology Innovaderm Research, recognized for its expertise in dermatology, is thrilled to announce an important new addition to its team. Dr. Juan Gabriel Ovalles Bonilla, MD, PhD, an accomplished and board-certified rheumatologist, will be joining Innovaderm. His extensive experience brings added strength to the company’s efforts...